Enhertu

This prescription medicine, also known as Trastuzumab deruxtecan, is utilized in the treatment of specific cancer types. It's an antibody-drug conjugate that combines the humanized monoclonal antibody trastuzumab with the topoisomerase I inhibitor deruxtecan. Its primary use is for treating breast cancer and gastric or gastroesophageal adenocarcinoma.